Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine on Alcohol Drinking in Heavy Drinkers
NCT06900998Phase 2Not yet recruiting
- Sponsor
- Yale University
- Start
- Sep 2026
- Primary completion
- Jun 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nimodipine in alcohol use disorder (AUD), sponsored by Yale University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nimodipine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06900998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06900998.